Pfizer (PFE) Non Operating Income (2010 - 2012)

Pfizer (PFE) has reported Non Operating Income for 3 consecutive years, with $293.0 million the latest figure, recorded in Q3 2012.

• On a quarterly basis, Non Operating Income rose 2.09% year-over-year to $293.0 million in Q3 2012; TTM through Jul 2012 was $1.2 billion, a 10.3% decrease from a year earlier, with the FY2011 full-year figure at $1.2 billion, down 12.33% from the prior year.
• Non Operating Income was $293.0 million for Q3 2012 at Pfizer, down from $309.0 million in the prior quarter.
• Over five years, Non Operating Income peaked at $410.0 million in Q2 2010 and troughed at $270.0 million in Q4 2011.
• A 3-year average of $322.0 million and a median of $311.0 million in 2011 frame the typical range for Non Operating Income.
• Across the five-year window, Non Operating Income slipped 23.73% in 2011 and climbed 2.09% in 2012, its largest moves.
• Over 3 years, Non Operating Income stood at $354.0 million in 2010, then declined by 23.73% to $270.0 million in 2011, then rose by 8.52% to $293.0 million in 2012.
• The last three Non Operating Income figures came in at $293.0 million (Q3 2012), $309.0 million (Q2 2012), and $270.0 million (Q4 2011), per Business Quant data.